Vanguard Capital Management
PFE icon

Vanguard Capital Management’s Pfizer PFE Stock Holding History

Vanguard Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.6B Buy
373,002,512
+852,660
+0.2% +$22.7M 0.22% 71
2026
Q2 		$8.96B Buy
372,149,852
+2,719,840
+0.7% +$71.1M 0.19% 82
2026
Q1 		$10.4B Buy
+369,430,012
New +$9.8B 0.26% 63

Other funds holding PFE

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Vanguard Capital Management's PFE Position: Q3 2026 in Review

Vanguard Capital Management increased its Pfizer (PFE) stake by 0.23% in Q3 2026, buying an estimated $22.7M and bringing the position to 373,002,512 shares worth $10.6B. The position accounts for 0.22% of the portfolio, ranked #71.

Vanguard Capital Management first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. 2,480 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Vanguard Capital Management held 373,002,512 shares of Pfizer worth $10.6B as of Q3 2026.
  • Vanguard Capital Management bought 852,660 Pfizer shares in Q3 2026, an estimated $22.7M.
  • Pfizer made up 0.22% of Vanguard Capital Management's portfolio in Q3 2026, its #71 holding.
  • Vanguard Capital Management first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
  • 2,480 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.